차입 증가 → 이자부담 → 수익성 악화
Critical부채가 +122.2% 늘며 이자보상배율이 -6.8x에서 -10.8x로 하락했다. ROE도 -84.9%에서 -138.0%로 낮아져 차입 부담이 수익성을 누르고 있다.
Evidence
PeopleBio's company information is shown as of 2026-11-20. It is a security listed on KOSDAQ, ticker 304840. There are 14 published related companies.
Quantus's relationship data lists competitors: Samsung Electronics, Samsung SDS, NAVER; customers: Microsoft, Alphabet Class A, Amazon Com and 4 more; suppliers: NVIDIA, Advanced Micro Devices, Intel Corporation and 1 more.
By revenue it ranks No. 290 of the 321 companies with revenue data in Healthcare, with less than 0.1% of the sector's total revenue.
The sector is fragmented: its top three companies hold 16.2% of revenue.
Auditable observations with the original numeric evidence.
부채가 +122.2% 늘며 이자보상배율이 -6.8x에서 -10.8x로 하락했다. ROE도 -84.9%에서 -138.0%로 낮아져 차입 부담이 수익성을 누르고 있다.
Evidence
Factual information, not investment advice.
A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
US name matches 2977/3610 · KR cache checked 3595/3595 stocks
Factual filing information, not investment advice.
2026-11-21 dataset